Concepedia

Second Primary Malignancies in Chronic Myeloid Leukemia

Binay Kumar Shah, Krishna Bilas Ghimire

Indian Journal of Hematology and Blood Transfusion · 2014 · 23 citations · 5 references

DOIFull text

Open access

Concepts

References

5

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.6K citations · Full text

, , +10

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

Ruth Seggewiss · Blood · 2004 · 290 citations · Full text

, , +9

Immunosuppression and Cancer

Israel Penn, Thomas E. Starzl · The Lancet · 1969 · 117 citations

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

Dushyant Verma, Hagop M. Kantarjian, Sara S. Strom et al. · Blood · 2011 · 104 citations · Full text

, , +16

Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US

Rakesh Mandal, Daniel M. Bolt, Binay Kumar Shah · Acta Oncologica · 2012 · 28 citations · Full text

, , +15